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Efficient generation of single 
domain antibodies with high 
affinities and enhanced thermal 
stabilities
Naoya Shinozaki1, Ryuji Hashimoto1, Kiichi Fukui2 & Susumu Uchiyama3,4
Single domain antibodies (sdAbs), made of natural single variable regions of camelid or cartilaginous 
fish antibodies, or unpaired variable regions of mouse or human IgGs, are some of the more promising 
biologic modalities. However, such conventional sdAbs have difficulties of either using unwieldy 
animals for immunization or having high affinity deficiencies. Herein, we offer a versatile method to 
generate rabbit variable domain of heavy chain (rVH) derived sdAbs with high affinities (KD values of 
single digit nM or less) and enhanced thermal stabilities (equal to or even higher than those of camelid 
derived sdAbs). It was found that a variety of rVH binders, including those with high affinities, were 
efficiently acquired using an rVH-displaying phage library produced at a low temperature of 16 °C. 
By a simple method to introduce an additional disulfide bond, their unfolding temperatures were 
increased by more than 20 °C without severe loss of binding affinity. Differential scanning calorimetry 
analysis suggested that this highly efficient thermal stabilization was mainly attributed to the entropic 
contribution and unique thermodynamic character of the rVHs.
Antibodies are being used for various therapeutic applications due to their high target specificity and biological 
functions. Most of them have been developed based on the robust natural format of human or humanized IgG. 
Fragment antibodies such as Fab, single chain fragment variable (scFv), and single domain antibody (sdAb) have 
also been utilized as promising modalities to create next-generation antibodies, like bi- or multi-specific antibod-
ies. Moreover, such fragment antibodies are expected to be an imaging reagent because their smaller molecular 
size enables high tissue penetration and rapid elimination from the body.
There are many reports on sdAbs composed of natural single heavy chain antibodies from camelids (VHH), 
and several reports on those of cartilaginous fishes (IgNAR)1, 2. As more available sources, variable regions of 
mouse or human antibodies have been employed for the creation of sdAbs3–8, however, these sdAbs showed lower 
binding affinities than those of IgG or VHH. The rabbit is another widely used animal for antibody acquisition. 
It is well known that rabbit IgGs generally show higher binding affinities than mouse IgGs9, 10, nevertheless, there 
are only a few reports regarding their variable regions. We hypothesized that rabbit variable regions may have the 
potential to be modified to the sdAb format.
At the beginning of this study, we hypothesized that rabbit variable domain of heavy chain (rVH) has the 
possibility of showing a higher binding affinity than rabbit variable domain of light chain (rVL), because rVH 
tends to have a longer CDR3 than rVL11, 12, which may create a larger diversity, wider binding surface area and 
higher specificity to various antigens. The very limited germ-line gene segment of rVH9, 11, 12 is also considered to 
be advantageous because its highly homologous framework would enable it to share various engineering benefits, 
such as humanization9.
Next, we considered the stabilizing effect of the VH-VL interaction to rVH13–15. To acquire rVH binders from 
immunized rabbits using a phage display system, rVHs separated from rVLs have to be displayed properly on the 
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phage. The temperature at which phages are produced in Escherichia coli (E. coli) is presumed to be the key to 
achieving this. Previously, an attempt was made to acquire rVH binders using an rVH-displaying phage library 
produced at 25 °C16, which is lower than the conventional temperature for rabbit scFv-displaying phages (30 °C or 
37 °C)17–19, resulting in obtainment of only weak binders. Thus, in this study, the temperature was further lowered 
to investigate its impact on the rVH display level and resulting acquisition of rVH binders.
In order to utilize rVHs for various applications, high thermal stability would be one of the most desired prop-
erties. There are many papers that shows improvement of physicochemical properties by phage display method. 
In such approaches, mutations are sometimes involved at or near the CDRs20, 21. To avoid the risk of affinity 
change by such mutations, we considered the enhancement of thermal stabilities of rVHs by introducing covalent 
bond into the fixed position of deep inside the framework. Other groups reported introduction of an additional 
(artificial) disulfide bond at the residues 54 and 78 of camelid VHH (IMGT numbering)22–24. Most of the VHHs 
were successfully stabilized by the disulfide bond with relatively small negative effect on the binding affinity to the 
antigen, while some VHHs lost their antigen binding abilities24. Therefore, we thought it intriguing to investigate 
the impact of the disulfide bond on the thermal stabilities and affinities of rVHs, and to learn what kind of factors 
control them.
In this study, we attempted to acquire a wide variety of rVHs against tumor antigens HER2 and HER3 through 
phage production at temperatures lower than 25 °C. The obtained rVHs were then characterized by antigen bind-
ing affinity and thermal stability. Finally, the new disulfide bond was introduced into obtained rVHs and its 
impact on the thermal stabilities and affinities was examined. We provide a new platform to generate potent and 
highly stable rVH derived sdAbs for various applications, including therapeutic uses.
Results
Phage production and acquisition of antigen specific rVHs. Our rVH binder acquisition process 
is summarized in Supplementary Figure S1. Briefly, we immunized rabbits with HER2 and HER3 antigens and 
confirmed the increased antibody titers of these antigens in the immunized rabbits (Supplementary Fig. S2). We 
used a total of 1.9 × 108 spleen and lymph node cells to amplify VH genes from these rabbits. rVH genes were 
amplified with designed primers (Supplementary Table S1) and inserted into phagemid vector. A total of 8.0 × 108 
transformants were obtained and it was expected that they would cover a wide variety of input rVH genes. For 
rVH-displayed phage production, we first cultivated the obtained transformants at several temperatures to inves-
tigate which temperature maximizes rVH display level. As shown in Fig. 1a, cultivation at 16 °C gave the strongest 
Figure 1. Panning against antigens with rVH-displaying phage. (a) Display level of rVHs on the phage 
produced at various temperatures. The phages were produced at 16, 20, 22 and 25 °C and subjected to WB 
(1.0 × 1010 virions per well). The rVH-gIIIp fusion protein was detected by anti-E-tag antibody and the amount 
of detected rVH-gIIIp fusion protein was correlated to the display level of rVHs. Fusion protein, which lacks 
an rVH portion, was also detected as a below band of the intact fusion protein. (b) Phage recovery rates after 
panning against HER2 or HER3. Gray bars indicate phage recovery rates (ratio of output to input phage) after 
each round of panning and black bars indicate phage recovery rates after the third round of panning without 
antigen.
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band intensity corresponding to rVH-gIIIp (gIII coat protein of M13 bacteriophage) fusion proteins, which are 
indicative of rVHs being displayed on the phage (Fig. 1a, upper band). The band become weaker as the cultivation 
temperature increased to 20 or 22 °C and was not detected at 25 °C. Thus, we adopted 16 °C as the cultivation 
temperature to produce an rVH-displaying phage library. The lower bands shown in Fig. 1a were considered to be 
impurities of rVH-gIIIp fusion proteins lacking the rVH region because their molecular weights (about 15 kDa) 
were consistent with the difference of molecular weight between the upper and lower bands. This consideration 
was supported by the fact that such an intense band was not observed for the control phage VCSM13, which is 
composed of only native gIIIp (Supplementary Fig. S3).
Starting from the prepared rVH phage library, phage recovery rates (numbers of output phage/input phage) 
increased step-wisely after every round of panning with each antigen (Fig. 1b). In the third round, remarka-
ble differences in the phage recovery rates were confirmed between the panning with and without antigens. 
These results indicated that antigen binding rVHs were concentrated from a vast number of library clones. 
After three rounds of panning, about 300 output clones were screened for their binding abilities to antigens by 
Enzyme-Linked ImmunoSorbent Assay (ELISA), and 55 and 125 hit clones were obtained for HER2 and HER3 
(Supplementary Fig. S1), respectively. These hit clones were subjected to sequence analysis and assessment of 
concentration-dependent binding to antigens (Supplementary Fig. S4). Non-specific binders were eliminated by 
counter screening for bovine serum albumin (BSA). Finally, eight rVHs were obtained respectively for both HER2 
and HER3 (whose names start with H2 and H3 as Fig. 2a).
Figure 2. Primary and tertiary structures of rVHs (a) Amino acid sequences of the obtained 16 rVHs and their 
consensus (Cons.) sequences are aligned according to IMGT and KABAT numbering. For each obtained rVH, 
only amino acids different from consensus sequences are indicated. The Cys positions for C23-C104 and C54-
C78 are linked with black lines and highlighted by yellow- and blue-filled frames, respectively. (b) The residues 
in the VL interacting surface (cyan or orange), a pair of Cys residues forming C23-C104 (yellow), and residues 
mutated to Cys for C54-C78 (blue) are indicated in the rVH structure (PDB ID: 4HBC). Figures were generated 
with PyMOL (The PyMOL Molecular Graphics System, 1.7.2.1 Schrodinger, LLC).
www.nature.com/scientificreports/
4Scientific RepoRts | 7: 5794  | DOI:10.1038/s41598-017-06277-x
Physico-chemical properties of antigen specific rVHs. We selected 5 hit clones from 16 clones in 
Supplementary Figure S4, which are two highly efficient ELISA binders (H2-2-2 and H3-15), moderate binder 
(H2-1-1) and two somewhat weak binders (H2-8 and H3-9), in order to assess the relationship between ELISA 
results and dissociation constants from SPR. We first tried to prepare these rVHs using E. coli and four rVHs 
except H2-1-1 could be obtained for enough amount to conduct physicochemical analysis. H2-1-1 were prepared 
using mammalian cell for physicochemical analysis. The purities of prepared rVHs were confirmed by SDS-PAGE 
analysis (Supplementary Fig. S5). rVHs commonly possess a disulfide bond between residues C23 and C104 
(C23-C104) and prepared rVHs showed the formation of C23-C104 in MS analysis (Supplementary Table S2). 
We confirmed by SEC-MALS analysis that all rVHs were detected as the single peak around 15 kDa (Table 1), 
indicative of monomeric and mono-disperse states for the rVHs. We measured the binding affinities of these 
rVHs to respective antigens by surface plasmon resonance (SPR) analysis. H2-2-2 and H3-15 showed KD values 
in a sub-nanomolar range; 0.4 nM for H2-2-2 and 0.8 nM for H3-15 (Table 1). KD values of other rVHs (H2-1-1, 
H2-8 and H3-9) were in the range of from two to three-digit nM. Regarding the thermal stability, unfolding tem-
perature (Tpeak) was determined by differential scanning calorimetry (DSC) analysis (Table 1). H2-1-1 and H2-2-2 
showed lower Tpeak values (47.9 and 37.7 °C, respectively) than those of H2-8, H3-9 and H3-15 (80.2, 66.9 and 
61.9 °C, respectively). We plotted Tpeak value and the purification yield in the E. coli expression system, and good 
correlation was observed between them (R² = 0.94, Supplementary Fig. S6).
Introduction of additional disulfide bond to rVHs. Aiming for thermal stability enhancements of the 
rVHs, we considered the introduction of an additional disulfide bond between residues 54 and 78 (Gly/Ala and 
Ile, blue-colored in Fig. 2a and b) based on the previous successful results in VHHs22–24. Because Cys is a hydro-
phobic amino acid, the residues of Cys mutations should be buried in a structure so as not to alter the hydro-
phobicity of the structure’s surface. In fact, accessible surface areas (ASAs) of residues mutated to Cys were less 
than 20% in the previous studies that reported the introduction of artificial disulfide bonds22. In order to estimate 
the ASA of residues for Cys mutation in the rVHs, we constructed model structures of five obtained rVHs using 
rabbit antibody structures that were available from a protein data bank (PDB) as a template (Supplementary 
Table S3). The estimated ASAs of the model structures were less than 10% (Supplementary Table S4), indicating 
that these residues were buried deep inside in the model structures. In order to investigate if the disulfide bond 
between C54 and C78 (C54-C78) would invoke structural alteration, we calculated the root mean square devia-
tion (RMSD) between each model structure of rVHs with and without C54-C78. The Cα RMSDs of the five rVHs 
showed values similar to that of VHH compared to the α-subunit of human chorionic gonadotropin (VHHhCG, 
PBD ID: 1HCV). Because VHHhCG was thermally stabilized by C54-C78 without loss of binding activity22, the 
introduction of C54-C78 was unlikely to have a negative impact on the rVHs’ binding affinities to antigens. Based 
on these considerations, in this study we attempted to introduce an additional disulfide bond into the wild type 
rVHs by Cys mutation of residues 54 and 78.
The rVHs whose residues 54 and 78 were mutated to Cys (C54-C78 mutant) were prepared by the same 
method as wild type rVHs and those purities were confirmed by SDS-PAGE analysis (Supplementary Fig. S5). It 
was not clearly observed that purification yields were improved by disulfide bond introduction under our prepa-
ration conditions using E. coli. In the case of H2-1-1, which was prepared using mammalian cell, purification 
yield of its C54-C78 mutant was increased to 3- or 7-fold compared with wild type. The formation of C54-C78 was 
experimentally confirmed by MS analysis after chymotrypsin digestion (Supplementary Table S4). Chymotrypsin 
digestion of mutant rVHs produced peptide fragments linked with C54-C78 or C23-C104 as expected. Neither 
undesired peptide fragments linked with other combinations of disulfide bond nor those with free Cys were 
detected. These results indicated that both of the two disulfide bonds were correctly formed as we had designed.
Physico-chemical properties of C54-C78 mutant rVHs. The antigen binding affinities of C54-C78 
mutant rVHs were evaluated by SPR. Their KD values, except for H3-9, were within several-fold of their respective 
wild type counterparts (Fig. 3a and Table 1). The affinities of rVHs in Fig. 3a (H2–2–2 and its C54-C78 mutant) 
SPR DSC SEC-MALS
kon (M−1 s−1) koff (s−1) KD (nM) Tpeak (°C) ∆Tpeak (°C) MWcal (kDa) MWexp (kDa)
H2-1-1
WT 7.3 × 104 1.6 × 10−3 22 47.9 15.3 17.0 ± 0.7
Mutant 1.5 × 105 1.4 × 10−2 92 78.2 30.3
H2-2-2
WT 8.2 × 105 3.3 × 10−4 0.4 37.7 16.0 18.9 ± 1.7
Mutant 6.1 × 105 1.6 × 10−3 2.7 60.4 22.7
H2-8
WT — — 390a 80.2 14.9 13.3 ± 0.5
Mutant — — 870a 100.8 20.6
H3-9
WT — — 190a 66.9 15.5 13.9 ± 0.6
Mutant — — >5000b 90.3 23.4
H3-15
WT 2.6 × 106 2.0 × 10−3 0.8 61.9 15.3 15.6 ± 1.2
Mutant 1.2 × 106 2.5 × 10−3 2.0 81.8 19.9
Table 1. Characterizations of antigen specific rVHs. MWcal: Molecular weight (MW) calculated from amino 
acid composition. MWexp: Experimentally obtained MW. aFor H2-8 and H3-9, KD values were determined by 
steady–state affinity analysis. bKD value for the C54-C78 mutant of H3-9 could not be determined up to 5 µM.
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were also evaluated with BioLayer Interferometry method (BLI method). Using BLI method, which is completely 
different biosensor system from SPR, we could obtain similar fold change in KD values as SPR between H2-2-2 
and its mutant (6.3 fold for BLI, 6.8 fold for SPR, Supplementary Fig. S7). The thermal stabilities of C54-C78 
mutants were evaluated (Table 1). The Tpeak values of all mutants were more than 20 °C higher than those of cor-
responding wild type rVHs, and remarkably, such Tpeak increases were much larger than those of previous results 
by VHHs22–24. rVHs can be highly thermally stabilized by C54-C78 introduction without severe loss of binding 
affinities.
In order to obtain information about the major factors that contributed to the high thermal stabilization men-
tioned above, the thermodynamic parameters and Tm, at which the Gibbs free energy change (ΔG) becomes zero, 
were determined for H2-2-2 and its C54-C78 mutant by DSC (Fig. 3b and Table 2). In comparison, those of 
VHHhCG were estimated based on the published data22 (Table 2). With the obtained thermodynamic parameters 
and Tm, ΔG values at each temperature (ΔG(T)s) were illustrated in Fig. 3c. The introduction of C54-C78 
increased ΔG of mutant of H2-2-2 and VHHhGC to the same extent at Tm of wild type (Tm
W). As for Tm, the Tm 
Figure 3. Physico-chemical properties of H2-2-2 and its C54-C78 mutant. (a) Observed sensorgrams (red) 
and fitting curves for single cycle kinetics (black) in the SPR analysis for H2-2-2. Data were collected at 
concentrations of 0.11, 0.37, 1.1, 3.3, 10 nM for H2-2-2 and 1.2, 3.7, 11, 33, 100 nM for its mutant. (b) The 
thermal unfolding curve of H2-2-2 (light blue) and its C54-C78 mutant (blue) in the DSC analysis. (c) The free 
energy change of H2-2-2 (blue) and VHHhCG (red). Solid lines indicate those of wild types and dashed lines 
indicate those of C54-C78 mutant. (d) The differences in the thermodynamic parameter change between H-2-
2-2 and its C54-C78 mutant. The differences in the change of free energy (ΔΔG), enthalpy (ΔΔH) and entropic 
term (TΔΔS) are indicated as the solid line, dashed line and dotted line, respectively.
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increase (ΔTm) of H2-2-2 was more than 20 °C (from 35.0 °C to 58.1 °C), while that of VHHhCG was 10 °C (from 
46.0 °C to 56.0 °C). Comparing ΔG(T) curves of mutants and wild types, C54-C78 introduction did not have large 
impact on the shape of the ΔG(T) curve itself. Regarding the enthalpy and entropy change accompanied by the 
thermal unfolding (ΔH and ΔS), the mutant of H2-2-2 showed the values of 162.2 kJ/mol and 489.7 J/mol/K, 
respectively. These values were less than half those of mutant of VHHhCG (369.2 kJ/mol and 1121.7 J/mol/K, 
respectively). In terms of the influence of the C54-C78 introduction on the ΔH and ΔS, compared to their wild 
types both ΔH and ΔS were slightly decreased for the mutant of H2-2-2 while were increased for the mutant of 
VHHhCG. The change in the heat capacity (ΔCP) of the mutant of H2-2-2 was 1.8 kJ/mol/K, which was one-third 
that of the mutant of VHHhCG. The C54-C78 introduction led to the slight increase in ΔCP of both mutants of 
H2-2-2 and VHHhCG compared to their wild types. Figure 3d shows the differences in the change of enthalpy, 
entropic term, and free energy (ΔΔH, TΔΔS and ΔΔG) between mutant and wild type of H2-2-2 at various 
temperatures. ΔΔH was negative but largely compensated by TΔΔS, resulting in a positive ΔΔG at all indicated 
temperatures.
Discussion
In this study, rVHs were shown to have the potential for specific binding to antigens with sub-nanomolar KD val-
ues. Based on our knowledge, this is the first report to obtain such high affinity binders composed of an unpaired 
variable region3–8. As correlation was observed for representative five rVHs between binding efficiencies of ELISA 
(Supplementary Fig. S4) and dissociation constants of SPR (Table 1), we consider that other ELISA binders such 
as H2-2-1 or H3-14, which are as efficient as H2-2-2 and H3-15, could also have smaller dissociation constants as 
those of H2-2-2 and H3-15. Physical stability of therapeutic proteins in solution is governed mainly by the com-
bination of conformational stability that corresponds to the free energy difference between native and denatured 
states and colloidal stability that reflects the dispersion state of the protein molecules25, 26. Upon considering the 
acquisition of the rVHs, their reduction in conformational stabilities was presumed because they lacked partner 
VLs13–15. In fact, the difference in the free energy between scFv and unpaired VH was calculated to be 9.0 kJ/mol 
from the denaturation curve in the previous report13. This large decrease in the stability elicited our concern that 
phage production at high temperatures would cause inefficient display of rVHs on the phage. The phage produced 
at 25 °C, which was used in the previous study16, did not show a detectable level of rVH display (Fig. 1a). While, 
the rVH display level was enhanced by lowering temperature and maximized at 16 °C. Using a rVH-displaying 
phage library produced at 16 °C, we could obtain a variety of HER2 and HER3 binders. Some of rVHs were poorly 
produced in E. coli and thermally unstable (Supplementary Fig. S6). This result implied that the lowered tem-
perature contributed to rVH binder acquisition by enhancing soluble expression27 of rVHs fused to gIIIp and/or 
suppressing thermal unfolding.
For industrial applications as therapeutic agents, a simple and universal method is strongly needed to enhance 
the thermal stability of rVHs. This study showed that the introduction of C54-C78 increased unfolding temper-
atures of rVHs, and surprisingly their shifts of unfolding temperature were much larger than those of VHHs22–24 
(24.0 °C for rVHs vs 9.0 °C for VHHs on average, Fig. 4). The thermal stabilities of mutant rVHs were comparable 
to those of mutant VHHs. We considered our approach is applicable not only to our representative rVHs but 
also any other rVHs because almost all of the rVH frameworks (80–90%) have high sequence similarity due to 
adopting only one germ-line gene segment9, 11, 12 and the beneficial mutations in the framework could be shared 
among the rVHs. To be employed for various applications, expression yield in E. coli might be one of the impor-
tant factors for sdAbs. Improvement of purification yield was not clearly observed by disulfide bond introduction 
under our preparation conditions, however, in the case of H2-1-1, purification yield increased by 3- or 7-fold due 
to disulfide bond introduction when it was prepared using mammalian cell. This result supports the correlation 
between thermal stabilities and purification yields as suggested in Supplementary Figure S6. Besides the confor-
mational stability, protein yield could be influenced by various factors including mRNA transcription and transla-
tion efficiency, folding efficiency, solubility, and so on. Therefore, by optimizing preparation conditions including 
modification of expression vectors and E. coli strains, introduction of disulfide bonds could increase purification 
yield using E. coli expression system.
We next examined the thermodynamic parameters to reveal the origin of the larger Tm increase in the 
C54-C78 mutant of H2-2-2 compared to the mutant of VHHhCG. The ΔG increase at each Tm
W (ΔΔG(Tm
W)) 
accompanied by the mutation was 9.9 kJ/mol for H2-2-2 and 10.4 kJ/mol for VHHhCG, which were almost the 
same values as one another. Then, under the condition where ΔΔG(Tm
W) is a constant value, we investigated how 
the Tms of mutant (Tm
W) changes when different values of other thermodynamic parameters are given. For simpli-
fication, we at first considered the case where ΔCP is zero and then ΔH and ΔS are constant. ΔG of mutant is 
indicated by Equation 1.
Tm (°C) ∆H (kJ/mol) ∆S (J/mol/K) ∆CP (kJ/mol/K)
H2-2-2
WT 35.1 161.4 ± 1.9 523.8 ± 6.0 1.5 ± 0.1
Mutant 58.1 158.6 ± 3.2 478.8 ± 9.6 1.7 ± 0.1
VHHhCG
WT 46.0 346.8 ± 5.4 1086.6 ± 16.9 4.8 ± 0.4
Mutant 56.0 369.2 ± 9.4 1121.7 ± 28.6 5.2 ± 0.4
Table 2. Thermodynamic parameters of H2-2-2 and VHHhCG. For VHHhCG, Tm and ∆CP were quoted from  
ref. 22 and other thermodynamic parameters were calculated using published data22.
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∆ = ∆ − ∆G H T S (1)
Here ΔG at Tm
W is expressed as ΔG°, while ΔG becomes zero at Tm
W, ΔH is indicated as Equations 2 and 3 from 
Equation 1.
∆ = ∆ ° + ∆H G T S (2)m
w
∆ = ∆H T S (3)m
M
From Equations 2 and 3, Tm
M can be indicated as Equation 4.









Equation 5 indicates that when ΔG° is unchanged, the smaller ΔS gives a larger ΔTm. In fact, when the ΔS of the 
mutant of VHHhCG (0.96 kJ/mol/K) was employed instead of that of the mutant of H2-2-2 (0.36 kJ/mol/K), the 
calculated ΔTm of the mutant of H2-2-2 decreased from 27 °C to 10 °C. Next, the ΔG of the mutant of H2-2-2 was 
calculated when its ΔCP (1.8 kJ/mol) takes zero or ΔCP of the mutant of VHHhCG (5.4 kJ/mol), under the condi-
tion that ΔG, ΔH and ΔS at Tm
W are unchanged (Supplementary Fig. S8). The smaller ΔCP apparently resulted in 
the smaller ΔG temperature dependence, and ΔCP of the mutant of H2-2-2 resulted in a ΔTm of 23 °C, which is 
higher than the ΔTm (19 °C) calculated using ΔCP of the mutant of VHHhCG. These estimations indicated that the 
small ΔS and ΔCP values of the mutant of H2-2-2 could be causes of its higher ΔTm.
As for the ΔG increase of the mutant of H2-2-2, Fig. 3d suggested the contribution of a large negative ΔΔS. 
In order to have further thermodynamic insight into the effect of C54-C78 introduction to rVHs, we compared 
experimental ΔΔS of H2-2-2 with its theoretical entropy change of unfolded state by C54-C78 formation (ΔScalc). 
In the classical chain-entropy model, an enhancement of stability by the disulfide bond formation is primarily 
considered to be attributed to ΔScalc28–31. The ΔScalc can be calculated using an equation28:
∆ = − +S R(3/2 ln N A) (6)calc
where, R is the universal gas constant (8.31 J/mol/K) and N is the number of residues in the disulfide bond-linked 
loops (21 residues). Constant A was proposed by Poland and Scheraga28 and Pace et al.29 as 3.5 and 1.1, respec-
tively. The ΔScalc values were respectively calculated to −66.7 and −46.7 J/mol/K with each constant A. Both of 
the ΔScalc values were far different from the experimentally obtained ΔΔS (−154.4 J/mol/K at 35.0 °C), indicat-
ing that the classical chain-entropy model cannot be applied to rVH. Such a large discrepancy suggests that the 
restricted chain configuration of the unfolded state could not be the only effect of the C54-C78 introduction for 
H2-2-2. Changes in the internal interaction and/or hydration state might be other effects contributing to the 
mutant of H2-2-2 ΔG increase as reported for VHHhCG22.
Figure 4. Comparison of increase in the unfolding temperature of rVHs and VHHs due to C54-C78 
introduction. Unfolding temperature of wild types and their corresponding C54-C78 mutants are indicated 
as the same symbol and color for rVH and VHH. Average thermal unfolding temperatures of each group are 
indicated with bold lines (rVHs = 58.7 °C, mutant rVHs = 82.7 °C, VHHs = 71.9 °C, mutant VHHs = 80.9 °C). 
The unfolding temperatures of VHHs were quoted from refs 22–24.
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In this study, we obtained rVHs without their partner rVLs by displaying only rVHs on the phage. Isolation 
of VH from Fv accompanies the exposure of the VL-interacting surface, which is generally composed of hydro-
phobic amino acids, to solvent. The exposure of the VL-interacting surface could cause intermolecular interac-
tions and thereby decrease colloidal stability, leading to undesirable non-specific oligomerizations and eventually 
aggregations26. The features of VL-interacting surfaces of rVHs obtained in this study were next investigated and 
compared with those of rVHs that were previously obtained as Fv32–35. The amino acid residues located on this 
surface (cyan-colored in Fig. 2b) are listed in Supplementary Figure S9a. Comparing the ASAs of our rVHs and 
rVHs from Fv, no significant difference was found in the ASA of non-polar groups (ASAnon-pol, Supplementary 
Fig. S9b). On the other hand, our rVHs showed a clear tendency of larger ASA polar groups (ASApol) than rVHs 
in Fv. Surprisingly, this significant difference was mainly attributed to only one amino acid at the residue 120. 
Most of the obtained rVHs had Gln at residue 120 while all rVHs in Fv had Pro. Compared with the Pro at residue 
120, Gln had a smaller ASAnon-pol (30 Å2–40 Å2 smaller) and larger ASApol (80 Å2–100 Å2 larger) (Supplementary 
Fig. S9c), providing a higher hydrophilic surface area at the VL-interacting surface of our rVHs. These results 
might originate from the elimination of rVHs with hydrophobic VL-interacting surfaces during the panning 
step using hydrophobic magnetic beads and microtubes. Considering that the VHHs, which are a natural sin-
gle domain variable region of camelids, also adopt Gln22–24, Gln at the residue 120 of sdAbs might generally be 
advantageous from the point of colloidal stability. Further investigation of colloidal stabilities, three-dimensional 
structures of rVHs, and their molecular states in highly concentrated solution36 will clarify the general rules of 
VH stabilization.
In conclusion, rVHs proved to have sufficiently high affinities that could not be achieved by VH from mice 
and human IgGs. The low thermal stability concern of rVHs was eliminated by introducing an additional disulfide 
bond. Thus rVHs are a promising new source of sdAbs, and their higher availability than conventional sdAbs 
would enable more frequent usage of sdAbs in various applications as therapeutic use.
Materials and Methods
Rabbit immunization. Three Japanese white rabbits (Inoue-shouten, Takasaki-Shi, Gunma, Japan) were 
immunized with a mixture of 33 μg of recombinant human ErbB-2/HER2 protein (ACROBiosystems, Newark, 
DE, USA) and recombinant human ErbB-3/HER3 protein (ACROBiosystems) in combination with Freund’s 
Complete Adjuvant. Seven days after the first immunization, rabbits were re-immunized with the same antigen 
mixture with Freund’s Incomplete Adjuvant, and this process was repeated eight times every two weeks. Seven 
days after the final immunization, rabbits were euthanized to isolate spleen and lymph node cells. The serum titers 
of each antigen were checked by Enzyme-Linked ImmunoSorbent Assay (ELISA) using HRP conjugated goat 
anti-Rabbit antibody (Immuno-Biological Laboratories Co., Ltd., IBL, Fujioka-Shi, Gunma, Japan) at seven days 
after the fourth, sixth and last immunization, respectively. All experiments with animals were approved by the 
Institutional Animal Care and Use Committee of Daiichi Sankyo and carried out in strict accordance with the IBL 
guidelines for animal experiments, which complies with the laws concerning animal protection and management.
Preparation of rVH-displaying phage library. From a total 1.9 × 108 spleen and lymph node cells 
of immunized rabbits, mRNAs were extracted using Dynabeads mRNA DIRECT Kit (Life Technologies 
Corporation, Grand Island, NY, USA) and reverse transcribed to cDNA with Transcriptor High Fidelity cDNA 
Synthesis Kit (Roche, Basel, Switzerland). Four 5′-sense and two 3′-antisense primers were designed to cover all 
rVH germ-line sequences (Supplementary Table S1) and used for polymerase chain reaction (PCR) to amplify 
rVH genes from the synthesized cDNA library. Amplified rVH genes were inserted into the Sfi I/Not I site of 
phagemid vector pCANTAB5E (Amersham plc, Buckinghamshire, UK) and fused following the 5′ end of the 
E-tag (GAPVPYPDPLEPR) and the gIII coat protein of M13 bacteriophage (gIIIp) coding sequence. E. coli 
TG-1 strain (Agilent Technologies, La Jolla, CA, USA) was transformed with these phagemid vectors. Obtained 
transformants were pooled and infected with enough amounts of helper phage VCSM13 (multiplicity of infec-
tion >100). Subsequently rVH displaying phages were produced by cultivation of these transformants at 16, 
20, 22 or 25 °C overnight with 2× YT medium supplemented with 0.25 mM IPTG, 100 μg/mL ampicillin, and 
50 μg/mL kanamycin. Produced phage was then precipitated from overnight cultured medium using polyeth-
ylene glycol 6,000 and dissolved with phosphate buffered saline (PBS). Comparison of rVH display levels on 
the phage, 1.0 × 1010 virions of phages, produced at each temperature were subjected to western blotting (WB) 
using anti-E-tag antibody (Bethyl Laboratories, Montgomery, TX, USA), and appropriate secondary antibodies 
were used for detections. Virion numbers of purified phages were quantified using spectrophotometry with the 
following formula37.
= − × ×Number of virions/mL (A A ) 6 10 /(number of nucleotide bases/virion)269 320
16
Here, A269 and A320 indicate UV absorption of 269 and 320 nm, respectively, and the number of nucleotide bases 
per virion was set to be 5000.
Panning against antigens. The rVH displaying phage library was first subjected to negative selection using 
Dynabeads M-280 Streptavidin (Life Technologies Corporation) without antigen for eliminating non-specific 
binders. All beads were previously blocked with BSA (Jackson ImmunoResearch Laboratories, Inc., West Grove, 
PA, USA) in all of the experiments. rVH-displaying phages unbound to the beads were then exposed to 50 pmol 
of biotinylated HER2 or HER3 at 4 °C for overnight (first round) or at room temperature for one hour (sec-
ond and third rounds). Biotinylated antigens were prepared using ChromaLink™ Biotin Antibody Labeling Kit 
(Solulink, Inc., San Diego, CA, USA) according to the manufacturer’s instructions. Subsequently, new beads were 
added to recover biotinylated antigen binders. Library treated beads were washed by three different conditions 
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as follows: PBS containing 3% (w/v) BSA and 0.05% Tween-20, PBS with 0.05% Tween-20, and PBS, respectively. 
Specific binders were eluted with 0.1 M Glycine-HCl (pH 2.2) and immediately neutralized with 1 M Tris-HCl 
(pH 8.0). After that, E. coli TG-1 strain was infected with eluted phages and cultivated on an LB agar plate sup-
plemented with 100 μg/mL of ampicillin. Appearing colonies were used for the next round of phage production 
or ELISA screening. Phage recovery rates of each round of panning were calculated as a ratio of input to output 
titer (colony forming unit for TG-1). To confirm the concentration of antigen specific binders, panning without 
antigen was also conducted as a negative control at the third round.
ELISA screening of antigen binding rVHs. A randomly selected 317 output colonies from the third 
panning were inoculated to 2× YT medium supplemented with 100 μg/mL of ampicillin and 0.1% (w/v) glucose 
and cultivated at 37 °C overnight. After final concentration of 0.5 mM, IPTG was added to induce rVH expression, 
and cultivation started again at 16 °C. Lysozymes were then added to overnight culture and the mixture was trans-
ferred to a Nunc MaxiSorp flat-bottom 96-well plate (Thermo Fisher Scientific, Inc., Waltham, MA, USA) pre-
coated with antigen (signal) or bovine serum albumin (noise). Bound rVHs were detected with HRP-conjugated 
anti-E-tag antibody (Bethyl laboratories) and >2.0 as a signal-to-noise ratio was set as the criterion for positive. 
Positive clones with repeatability were regarded as a hit.
Preparation of rVHs. Genes encoding hit rVH clones were genetically linked with FLAG and His tag by 
PCR and inserted into pFLAG-CTS vector (Sigma-Aldrich, St. Louis, MO, USA) by homologous recombination. 
E. coli BL21 (DE3) strain (Merck Millipore, Darmstadt, Germany) was transformed with expression vector and 
obtained transformants were grown in LB medium supplemented with 100 μg/mL of ampicillin. When optical 
density at 600 nm reached to 1.0, rVH expression was induced by addition of IPTG at a final concentration of 
1 mM and cultured at 16 °C for overnight. Infected cell and culture medium was separated by centrifugation and 
collected cell pellets were subjected to osmotic shock with 20 mM Tris-HCl pH 8.0 supplemented with 0.5 M 
sucrose and 0.1 mM EDTA. The osmotic shocked supernatant was mixed with the cultured medium, and rVH 
was affinity purified from this mixture by using Ni Sepharose excel (GE Healthcare UK Ltd., Little Chalfont, 
Buckinghamshire, England). Concentration dependent ELISA were conducted using affinity purified rVHs, and 
as for VHs for evaluations of binding affinity and thermal stability, affinity purified rVHs were further purified 
with gel filtration using a Superdex 75 10/300 GL with AKTA system (GE Healthcare UK Ltd). rVH of the clone, 
H2-1-1, was prepared using an Expi293F mammalian cell expression system (Life Technologies Corporation) 
according to the manufacturer’s instructions. Genes encoding H2-1-1 or its C54-C78 mutant with FLAG and His 
tags were sub-cloned into pcDNA3.1 vector for mammalian expression and expressed H2-1-1 rVH was purified 
similarly to rVHs using an E. coli expression system. The purities of finally purified rVH samples were confirmed 
by SDS-PAGE analysis and the protein concentrations were determined from the absorbance of 280 nm with 
the extinction coefficients which were calculated from amino acid sequences in Fig. 2a using Sednterp ver. 1.09 
(University of New Hampshire, USA).
Physico-chemical property analysis of rVHs. Binding activities of hit rVHs were evaluated by ELISA 
at concentrations of 16, 125 and 1000 nM of affinity purified rVH with HRP conjugated anti-FLAG M2 antibody 
(Sigma-Aldrich). Those that showed apparent differences in intensities between antigen and BSA were regarded 
as antigen specific rVHs. Binding affinities were measured at 25 °C by SPR using BIAcore T200 with a Series S 
Sensor Chip CM5 (GE Healthcare UK Ltd) coated directly with HER2 or indirectly by ErbB3 Fc Chimera (R&D 
Systems, Inc., Minneapolis, MN, USA) via Human Antibody Capture Kit (GE Healthcare UK Ltd). The kinetic 
parameters were determined by a 1:1 binding model of single cycle kinetics using BIAcore T200 Software. For 
H2-2-2 and its C54-C78 mutant, binding affinities were re-evaluated with BLI method using Octet RED 384 sys-
tem (Pall ForteBio LLC, Fremont, CA, USA) with Dip and Read™ Streptavidin Biosensors (Pall ForteBio LLC) 
coated with biotinylated HER2.
To estimate the molecular state of rVHs, SEC-MALS analysis was conducted using a DAWN HELEOS II 8+ 
(Wyatt Technology Corp, USA, Santa Barbara, CA) with a Sepax Zenix-C SEC-300 column (Sepax Technologies, 
Inc., USA, Newark, DE).
Regarding thermodynamic analysis, DSC was conducted using a MicroCal VP-Capillary DSC (Malvern 
Instruments Ltd, Worcestershire, UK.) at a heating rate of 60 °C/h. To evaluate thermal stability, the Tpeak value 
(temperature where heat capacity takes the maximal value) was determined with rVH samples at a concentra-
tion of 0.2 mg/mL in PBS using the software MicroCal Origin 7 (Malvern). To obtain detailed thermodynamic 
parameters, DSC analysis was conducted at 1.0 mg/mL. The ΔH values were estimated by the integration of 
endothermic heat accompanied by the unfolding. The Tm values were determined as the temperature at which the 
integration of endothermic heat is equal to half the area of ΔH. The enthalpy change (ΔH(T)), entropy change 
(ΔS(T)) and free energy change (ΔG(T)) are indicated as Equations 7–9.
∆ = ∆ + ∆ −H T H C T T( ) ( ) (7)P m
∆ = ∆ + ∆S T S C T T( ) ln( / ) (8)P m
∆ = ∆ − ∆G T H T T S T( ) ( ) ( ) (9)
From Equations 7–9, ΔS can be calculated as ΔH/Tm because ΔG becomes zero at Tm. In this analysis, we 
assumed that ΔCP was constant and determined as the difference between the baseline of folded and unfolded 
states in the DSC curve.
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Model structure construction and structural analysis. Model structures for obtained rVHs were con-
structed with the antibody structure prediction function of BioLuminate (Schrodinger, New York, NY). The PDB 
data, which were employed to construct the model structure, are listed in Supplementary Table S3. To argue the 
possibility of additional disulfide bond introduction to rVHs, model structures of rVHs with additional disulfide 
bonds were created using the function of Discovery Studio Ver. 4.0 (Accelrys, San Diego, CA, USA). Structural 
analysis of VHHhCG was conducted using available PDB data (PDB ID: 1HCV). The ASA of residues for Cys 
mutation and estimated RMSD of Cα of residues in the framework were calculated using Discovery Studio Ver. 
4.0. To estimate hydrophobicity of VL-interacting surfaces in obtained rVHs, the ASApol and ASAnon-pol of resi-
dues located at the VL-interacting surface were calculated using Discovery Studio Ver. 4.0. The residues of rVH in 
the VL interacting surface were defined as the common residues, which are less than 5 Å from its VL, in the rVH 
of available rabbit Fv structures (PDB ID: 4HBC, 4HT1, 4JO1, 4JO4, 4O4Y). The ASAs of these rVHs, which were 
originally obtained as Fv32–35, were also calculated with the three dimensional coordinates of the VH without the 
VL portion, which had been derived from the crystal structures of the Fv.
Introduction of additional disulfide bonds to rVHs. For additional disulfide bond introduction, Gly or 
Ala and Ile at positions 54 and 78 of rVHs were both mutated to Cys by site-directed mutagenesis. Cys introduced 
mutants were prepared by the same methods as wild type rVHs, and disulfide formations were confirmed for 
H2-1-1, H3-9, and H3-15 as follows. rVHs and their mutants were treated with sequencing grade chymotrypsin 
(Roche, Basel, Switzerland) at 37 °C for 4 hours followed by addition of 10% formic acid, and then subjected to 
LC-MS analysis using a Waters Synapt G2S (Waters Corporation, Milford, MA, USA). Peptide identification was 
conducted with MassLynx Mass Spectrometry Software ver. 4.1 and BiopharmaLynx Software ver. 1.3 (Waters 
Corporation).
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